Business · 12/04/2021
FDA Reopens Comment Period for Antimicrobial Drug Ranking Proposal
The US Food and Drug Administration (FDA) is reopening the comment period for a proposed approach to ranking antimicrobial drugs according to their importance in human medicine, in response to technical difficulties with submitting comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →